We propose that acquiring the ability to express IL-1 (a myeloid-specific protein) could induce epithelial-mesenchymal transition (EMT)-like transformation of glioma cells resulting in increased migratory capacity, a unique gene signature and increased immune signaling (NF-κB, pSTAT3). This evidence concerns the gene IL1A and glioma.